- Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 08, 2024₪58.15 (+12.96%)Earnings
- Q4 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJan 31, 2024₪44 (+3.87%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 08, 2023₪35.41 (-0.25%)Earnings
- Teva Pharmaceutical Industries Ltd to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 02, 2023₪34.57 (+13.23%)Earnings
- Teva Pharmaceutical Industries Ltd Investor Day TranscriptMay 18, 2023
- Q1 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 10, 2023₪30.59 (-8.00%)Earnings
- Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 08, 2023₪35.79 (-3.66%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 03, 2022₪31.01 (-2.55%)Earnings
- Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 27, 2022₪30.16 (+21.12%)Earnings
- Q1 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 03, 2022₪29.32 (+1.95%)Earnings
- Q4 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 09, 2022₪29.75 (+10.51%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptOct 27, 2021₪29.15 (-6.72%)Earnings
- Q2 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 28, 2021₪31.95 (+12.03%)Earnings
- Q1 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptApr 28, 2021₪32.71 (-1.86%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 10, 2021₪38.6 (-9.16%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 05, 2020₪28.85 (-8.30%)Earnings
- Q2 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 05, 2020₪42.7 (+3.69%)Earnings
- Q1 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 07, 2020₪41.48 (+17.84%)Earnings
- Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 12, 2020₪46.45 (+8.02%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 07, 2019₪31.32 (+5.88%)Earnings
- Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 07, 2019₪22.9 (-13.29%)Earnings
- Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 02, 2019₪54.49 (-0.04%)Earnings
- Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 13, 2019₪64.24 (-7.69%)Earnings
Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Teva today at the 40th Annual JPMorgan Conference. From the company, we have Kare Schultz, President and CEO. (Operator Instructions)
And so with that, Kare, Happy New Year. Thanks for joining us, and looking forward to your remarks.
Thank you very much, Chris, and welcome to all of you listening in and watching this. I would like to address four important issues that are of high relevance to us in Teva. First, I would like to give you an update on how we plan to solve the litigation challenges we have on the opioid litigation and what the status is. Then I'll give you an idea about how we are going about optimizing our business, focus on the progress we're making on reducing our debt. And then last but not least, I'll explain how we're securing our future sales growth.
But let's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)